SGLT2 inhibitor ameliorates hypertension by regulating the CYP4A/20-HETE pathway in the kidney

More on Hypertension

• Semaglutide may protect kidneys by reducing vascular resistance

  Nature Medicine · 4 Oct 2026

  

• Female hypertension links to a blood gene signature

  medRxiv · 4 Oct 2026

• Mild caloric restriction accelerates atherosclerosis in mice

  JCI Insight · 4 Oct 2026

• Cardiovascular risk from metabolic burden weakens with age

  The Lancet Regional Health Western Pacific · 4 Oct 2026